Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2016, Article ID 1657078, 7 pages
http://dx.doi.org/10.1155/2016/1657078
Research Article

Evaluation of Retinal and Choroidal Thickness in Fuchs’ Uveitis Syndrome

Ophthalmology Department, School of Medicine, Istanbul Medipol University, 34214 Istanbul, Turkey

Received 6 March 2016; Revised 20 June 2016; Accepted 30 June 2016

Academic Editor: Enrico Peiretti

Copyright © 2016 Ozlem Balci and Mustafa Ozsutcu. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. P. Herbort and N. Bouschenaki, “Fuchs' uveitis,” in Spectral-Domain Optical Coherence Tomography Imaging of the Eye, A. Vinekar and K. Avadhani, Eds., pp. 439–441, Elsevier Health Sciences, 2013. View at Google Scholar
  2. I. R. Schwab, “The epidemiologic association of Fuchs' heterochromic iridocyclitis and ocular toxoplasmosis,” American Journal of Ophthalmology, vol. 111, no. 3, pp. 356–362, 1991. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Rodriguez, M. Calonge, M. Pedroza-Seres et al., “Referral patterns of uveitis in a tertiary eye care center,” Archives of Ophthalmology, vol. 114, no. 5, pp. 593–599, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. D. C. Gritz and I. G. Wong, “Incidence and prevalence of uveitis in Northern California, the Northern California Epidemiology of Uveitis Study,” Ophthalmology, vol. 111, no. 3, pp. 491–500, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. V. T. Tran, C. Auer, Y. Guex-Crosier et al., “Epidemiological characteristics of uveitis in Switzerland,” International Ophthalmology, vol. 18, no. 5, pp. 293–298, 1994-1995. View at Google Scholar
  6. S. P. Chee and A. Jap, “Presumed fuchs heterochromic iridocyclitis and Posner-Schlossman syndrome: comparison of cytomegalovirus-positive and negative eyes,” American Journal of Ophthalmology, vol. 146, no. 6, pp. 883–889.e1, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. U. V. Jurkunas, M. S. Bitar, and I. M. Rawe, “Colocalization of increased transforming growth factor-β-induced protein (TGFBIp) and clusterin in fuchs endothelial corneal dystrophy,” Investigative Ophthalmology and Visual Science, vol. 50, no. 3, pp. 1129–1136, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. R. N. Van Gelder, “Idiopathic no more: clues to the pathogenesis of fuchs heterochromic iridocyclitis and glaucomatocyclitic crisis,” American Journal of Ophthalmology, vol. 145, no. 5, pp. 769–771, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. M. T. de Abreu, R. Belfort Jr., and P. S. Hirata, “Fuchs' heterochromic cyclitis and ocular toxoplasmosis,” American Journal of Ophthalmology, vol. 93, no. 6, pp. 739–744, 1982. View at Publisher · View at Google Scholar · View at Scopus
  10. E. La Hey, A. Rothova, G. S. Baarsma, J. De Vries, F. Van Knapen, and A. Kijlstra, “Fuchs' heterochromic iridocyclitis is not associated with ocular toxoplasmosis,” Archives of Ophthalmology, vol. 110, no. 6, pp. 806–811, 1992. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Teyssot, N. Cassoux, P. Lehoang, and B. Bodaghi, “Fuchs heterochromic cyclitis and ocular toxocariasis,” American Journal of Ophthalmology, vol. 139, no. 5, pp. 915–916, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. P. I. Murray, R. Hoekzema, M. A. C. van Haren, F. D. De Hon, and A. Kijlstra, “Aqueous humor interleukin-6 levels in uveitis,” Investigative Ophthalmology and Visual Science, vol. 31, no. 5, pp. 917–920, 1990. View at Google Scholar · View at Scopus
  13. P. Labalette, D. Caillau, C. Grutzmacher, J.-P. Dessaint, and M. Labalette, “Highly focused clonal composition of CD8+ CD28neg T cells in aqueous humor of Fuchs heterochromic cyclitis,” Experimental Eye Research, vol. 75, no. 3, pp. 317–325, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. B. M. Spriewald, C. Lefter, I. Huber, B. Lauer, and H. Wenkel, “A suggestive association of fuchs heterochromic cyclitis with cytotoxic T cell antigen 4 gene polymorphism,” Ophthalmic Research, vol. 39, no. 2, pp. 116–120, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. L. de Visser, A. Braakenburg, A. Rothova, and J. H. de Boer, “Rubella virus-associated uveitis: clinical manifestations and visual prognosis,” American Journal of Ophthalmology, vol. 146, no. 2, pp. 292–297, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Stunf, M. Petrovec, N. Žigon et al., “High concordance of intraocular antibody synthesis against the rubella virus and fuchs heterochromic uveitis syndrome in Slovenia,” Molecular Vision, vol. 18, pp. 2909–2914, 2012. View at Google Scholar · View at Scopus
  17. B. Wensing, L. M. Relvas, L. E. Caspers et al., “Comparison of rubella virus- and herpes virus-associated anterior uveitis: clinical manifestations and visual prognosis,” Ophthalmology, vol. 118, no. 10, pp. 1905–1910, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. J. D. F. De Groot-Mijnes, N. H. Ten Dam-van Loon, A. J. L. Weersink, A. M. Van Loon, and A. Rothova, “Relationship between rubella virus and Fuchs heterochromic uveitis; 2 patients,” Nederlands Tijdschrift voor Geneeskunde, vol. 151, no. 47, pp. 2631–2634, 2007. View at Google Scholar · View at Scopus
  19. J. D. F. De Groot-Mijnes, L. De Visser, A. Rothova, M. Schuller, A. M. Van Loon, and A. J. L. Weersink, “Rubella virus is associated with Fuchs heterochromic iridocyclitis,” American Journal of Ophthalmology, vol. 141, no. 1, pp. 212–214, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. C. D. Quentin and H. Reiber, “Fuchs heterochromic cyclitis: rubella virus antibodies and genome in aqueous humor,” American Journal of Ophthalmology, vol. 138, no. 1, pp. 46–54, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. Q. Mohamed and E. Zamir, “Update on Fuchs' uveitis syndrome,” Current Opinion in Ophthalmology, vol. 16, no. 6, pp. 356–363, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Melamed, M. Lahav, U. Sandbank, Y. Yassur, and I. Ben-Sira, “Fuch's heterochromic iridocyclitis: an electron microscopic study of the iris,” Investigative Ophthalmology and Visual Science, vol. 17, no. 12, pp. 1193–1199, 1978. View at Google Scholar · View at Scopus
  23. M. F. Goldberg, Y. S. Erozan, J. R. Duke, and J. K. Frost, “Cytopathologic and histopathologic aspects of Fuchs' heterochromic iridocyclitis,” Archives of Ophthalmology, vol. 74, no. 5, pp. 604–609, 1965. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Bouchenaki and C. P. Herbort, “Fluorescein angiographic findings and clinical features in Fuchs' uveitis,” International Ophthalmology, vol. 30, no. 5, pp. 511–519, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Bouchenaki and C. P. Herbort, “Fuch's uveitis: failure to associate vitritis and disc hyperfluorescence with the disease is the major factor for misdiagnosis and diagnostic delay,” Middle East African Journal of Ophthalmology, vol. 16, no. 4, pp. 239–244, 2009. View at Google Scholar
  26. S. Aziz, B. Arya, M. Westcott, and C. Pavesio, “An Investigation of the disc hyperfluorescence in Fuchs uveitis syndrome using optical coherence tomography imaging,” Ocular Immunology and Inflammation, vol. 23, no. 2, pp. 152–156, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. I. Tugal-Tutkun, E. Güney-Tefekli, F. Kamacı-Duman, and I. Corum, “A cross-sectional and longitudinal study of Fuchs uveitis syndrome in Turkish patients,” American Journal of Ophthalmology, vol. 148, no. 4, pp. 510–515.e1, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. R. F. Spaide, H. Koizumi, and M. C. Pozonni, “Enhanced depth imaging spectral-domain optical coherence tomography,” American Journal of Ophthalmology, vol. 146, no. 4, pp. 496–500, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Kardes, B. I. Sezgin Akçay, C. Unlu, and A. Ergin, “Choroidal thickness in eyes with fuchs uveitis syndrome,” Ocular Immunology and Inflammation, vol. 14, pp. 1–8, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. S. J. Kimura, M. J. Hogan, and P. Thygeson, “Fuchs' syndrome of heterochromic cyclitis,” Arch Ophthalmology, vol. 54, no. 2, pp. 179–186, 1955. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Nakayama, H. Keino, A. A. Okada et al., “Enhanced depth imaging optical coherence tomography of the choroid in Vogt-Koyanagi-Harada disease,” Retina, vol. 32, no. 10, pp. 2061–2069, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. I. Maruko, T. Iida, Y. Sugano et al., “Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease,” Retina, vol. 31, no. 3, pp. 510–517, 2011. View at Publisher · View at Google Scholar
  33. S. Ishikawa, M. Taguchi, T. Muraoka, Y. Sakurai, T. Kanda, and M. Takeuchi, “Changes in subfoveal choroidal thickness associated with uveitis activity in patients with Behçet's disease,” British Journal of Ophthalmology, vol. 98, no. 11, pp. 1508–1513, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Kim, H. Kim, H. J. Kwon, S. S. Kim, H. J. Koh, and S. C. Lee, “Choroidal thickness in Behcet's uveitis: an enhanced depth imaging-optical coherence tomography and its association with angiographic changes,” Investigative Ophthalmology and Visual Science, vol. 54, no. 9, pp. 6033–6039, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Akçar, F. Göktekin, A. Özer, and C. Korkmaz, “Doppler sonography of ocular and carotid arteries in Behçet patients,” Journal of Clinical Ultrasound, vol. 38, no. 9, pp. 486–492, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Kim, S. S. Kim, H. J. Kwon, H. J. Koh, and S. C. Lee, “Association between choroidal thickness and ocular perfusion pressure in young, healthy subjects: enhanced depth imaging optical coherence tomography study,” Investigative Ophthalmology and Visual Science, vol. 53, no. 12, pp. 7710–7717, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Coskun, B. Gurler, Y. Pehlivan et al., “Enhanced depth imaging optical coherence tomography findings in Behçet disease,” Ocular Immunology and Inflammation, vol. 21, no. 6, pp. 440–445, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. O. A. Maneschg, É. Volek, J. Németh et al., “Spectral domain optical coherence tomography in patients after successful management of postoperative endophthalmitis following cataract surgery by pars plana vitrectomy,” BMC Ophthalmology, vol. 14, article 76, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. W. Rahman, F. K. Chen, J. Yeoh, P. Patel, A. Tufail, and L. Da Cruz, “Repeatability of manual subfoveal choroidal thickness measurements in healthy subjects using the technique of enhanced depth imaging optical coherence tomography,” Investigative Ophthalmology & Visual Science, vol. 52, no. 5, pp. 2267–2271, 2011. View at Publisher · View at Google Scholar · View at Scopus